{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:43:40Z","timestamp":1791297820453,"version":"4.1.0"},"reference-count":154,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.cpcardiol.2011.08.002","type":"journal-article","created":{"date-parts":[[2011,10,29]],"date-time":"2011-10-29T02:24:43Z","timestamp":1319855083000},"page":"461-517","source":"Crossref","is-referenced-by-count":48,"title":["Pulmonary Arterial Hypertension"],"prefix":"10.1016","volume":"36","author":[{"given":"Vallerie V.","family":"McLaughlin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Cornwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2011.08.002_bib1","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/0002-9343(51)90020-4","article-title":"Primary pulmonary hypertension. I. Clinical and hemodynamic study","volume":"11","author":"Dresdale","year":"1951","journal-title":"Am J Med"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib2","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jacc.2009.04.012","article-title":"Updated clinical classification of pulmonary hypertension","volume":"54","author":"Simonneau","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib3","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1164\/rccm.200510-1668OC","article-title":"Pulmonary arterial hypertension in France: Results from a national registry","volume":"173","author":"Humbert","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib4","first-page":"789","article-title":"[Pulmonary artery hypertension associated with connective tissue diseases]","volume":"32","author":"Sanchez","year":"2003","journal-title":"Presse Med"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib5","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1002\/art.21433","article-title":"Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study","volume":"52","author":"Hachulla","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib6","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/ard.62.11.1088","article-title":"Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: Application of a registry approach","volume":"62","author":"Mukerjee","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib7","first-page":"282","article-title":"Pulmonary hypertension in systemic lupus erythematosus: Evaluation of clinical characteristics and response to immunosuppressive treatment","volume":"29","author":"Tanaka","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib8","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1164\/rccm.200704-541OC","article-title":"Prevalence of hiv-related pulmonary arterial hypertension in the current antiretroviral therapy era","volume":"177","author":"Sitbon","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib9","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2165\/00003495-200868080-00004","article-title":"Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger's syndrome","volume":"68","author":"Galie","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ccm.2006.12.001","article-title":"Pulmonary hypertension associated with left-sided heart disease","volume":"28","author":"Oudiz","year":"2007","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib11","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0735-1097(92)90050-W","article-title":"Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: Testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group","volume":"19","author":"Costard-J\u00e4ckle","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib12","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/thx.36.10.752","article-title":"Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease","volume":"36","author":"Weitzenblum","year":"1981","journal-title":"Thorax"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib13","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1183\/09031936.00171307","article-title":"Pulmonary hypertension in interstitial lung disease","volume":"31","author":"Behr","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib14","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1378\/chest.127.5.1531","article-title":"Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation","volume":"127","author":"Thabut","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib15","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1183\/09031936.04.00079704","article-title":"Chronic thromboembolic pulmonary hypertension","volume":"23","author":"Dartevelle","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib16","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1056\/NEJM199207093270202","article-title":"An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension","volume":"327","author":"Christman","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib17","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1378\/chest.120.5.1562","article-title":"Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension","volume":"120","author":"Rubens","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib18","doi-asserted-by":"crossref","first-page":"62S","DOI":"10.1016\/j.jacc.2004.02.042","article-title":"Endothelin receptor antagonists in pulmonary arterial hypertension","volume":"43","author":"Channick","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1006\/pupt.2000.0242","article-title":"Importance of local production of endothelin-1 and of the ET(B)Receptor in the regulation of pulmonary vascular tone","volume":"13","author":"Dupuis","year":"2000","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib20","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJM199507273330403","article-title":"Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension","volume":"333","author":"Giaid","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib21","first-page":"L46","article-title":"Serotonin produces both hyperplasia and hypertrophy of bovine pulmonary artery smooth muscle cells in culture","volume":"266","author":"Lee","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0002-9343(99)80156-9","article-title":"Increased plasma serotonin in primary pulmonary hypertension","volume":"99","author":"Herv\u00e9","year":"1995","journal-title":"Am J Med"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib23","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1164\/rccm.200210-1212OC","article-title":"Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension","volume":"168","author":"Marcos","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib24","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1475-097X.1993.tb00482.x","article-title":"Effect of vasoactive intestinal polypeptide (VIP) on pulmonary ventilation-perfusion relationships and central haemodynamics in healthy subjects","volume":"13","author":"S\u00f6derman","year":"1993","journal-title":"Clin Physiol"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib25","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1172\/JCI17500","article-title":"Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension","volume":"111","author":"Petkov","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib26","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jacc.2009.04.006","article-title":"Inflammation, growth factors, and pulmonary vascular remodeling","volume":"54","author":"Hassoun","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib27","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1183\/09031936.02.00081302","article-title":"Pathobiology of pulmonary arterial hypertension","volume":"20","author":"Eddahibi","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib28","doi-asserted-by":"crossref","first-page":"216","DOI":"10.7326\/0003-4819-107-2-216","article-title":"Primary pulmonary hypertension.","volume":"107","author":"Rich","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib29","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0140-6736(98)02111-4","article-title":"Primary pulmonary hypertension","volume":"352","author":"Gaine","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJM199701093360207","article-title":"Primary pulmonary hypertension","volume":"336","author":"Rubin","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib31","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJM199608293350901","article-title":"Appetite-suppressant drugs and the risk of primary pulmonary hypertension","volume":"335","author":"Abenhaim","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib32","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/0735-1097(91)90688-6","article-title":"Clinical and pathologic manifestations of pulmonary vascular disease in the toxic oil syndrome","volume":"18","author":"Gomez-Sanchez","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib33","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/00007611-199209000-00005","article-title":"Eosinophilia-myalgia syndrome: the aftermath","volume":"85","author":"Sack","year":"1992","journal-title":"South Med J"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib34","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1378\/chest.130.6.1657","article-title":"Is methamphetamine use associated with idiopathic pulmonary arterial hypertension?","volume":"130","author":"Chin","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib35","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1378\/chest.108.4.1140","article-title":"Stimulant-induced pulmonary toxicity","volume":"108","author":"Albertson","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib36","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/jmg.37.10.741","article-title":"Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family","volume":"37","author":"Thomson","year":"2000","journal-title":"J Med Genet"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1164\/ajrccm.152.1.7599869","article-title":"Genetic anticipation and abnormal gender ratio at birth in familial primary pulmonary hypertension","volume":"152","author":"Loyd","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib38","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1378\/chest.122.2.524","article-title":"Electrocardiography to define clinical status in primary pulmonary hypertension and pulmonary arterial hypertension secondary to collagen vascular disease","volume":"122","author":"Ahearn","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib39","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1378\/chest.121.2.513","article-title":"The prognostic role of the ECG in primary pulmonary hypertension","volume":"121","author":"Bossone","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib40","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.ehj.2004.09.014","article-title":"Guidelines on diagnosis and treatment of pulmonary arterial hypertension","volume":"25","author":"Gali\u00e8","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib41","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0002-9149(03)00136-X","article-title":"Frequency and severity of tricuspid regurgitation determined by Doppler echocardiography in primary pulmonary hypertension","volume":"91","author":"Hinderliter","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib42","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0272-5231(05)70286-0","article-title":"The assessment of pulmonary hypertension","volume":"22","author":"McGoon","year":"2001","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib43","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1161\/hc4801.100076","article-title":"Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects","volume":"104","author":"McQuillan","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib44","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1161\/CIRCULATIONAHA.109.192230","volume":"119","author":"McLaughlin","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib45","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0735-1097(85)80477-0","article-title":"Continuous wave Doppler determination of right ventricular pressure: A simultaneous Doppler-catheterization study in 127 patients","volume":"6","author":"Currie","year":"1985","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib46","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0002-9149(98)00140-4","article-title":"Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension","volume":"81","author":"Yeo","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib47","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1164\/rccm.200604-547OC","article-title":"Tricuspid annular displacement predicts survival in pulmonary hypertension","volume":"174","author":"Forfia","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib48","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1161\/01.CIR.80.2.353","article-title":"Two-dimensional and Doppler-echocardiographic and cardiac catheterization correlates of survival in primary pulmonary hypertension","volume":"80","author":"Eysmann","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib49","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0002-9149(99)00342-2","article-title":"Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension. PPH Study Group. Primary pulmonary hypertension","volume":"84","author":"Hinderliter","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib50","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0735-1097(02)01744-8","article-title":"Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension","volume":"39","author":"Raymond","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib51","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/eurheartj\/ehl477","article-title":"Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension","volume":"28","author":"van Wolferen","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib52","first-page":"793","article-title":"Ventilation-perfusion lung scanning in the evaluation of pulmonary hypertension","volume":"35","author":"Worsley","year":"1994","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib53","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJMra010902","article-title":"Chronic thromboembolic pulmonary hypertension","volume":"345","author":"Fedullo","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib54","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1378\/chest.93.6.1180","article-title":"Perfusion scan findings understate the severity of angiographic and hemodynamic compromise in chronic thromboembolic pulmonary hypertension","volume":"93","author":"Ryan","year":"1988","journal-title":"Chest"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib55","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/00003072-199308000-00012","article-title":"Segmental contour pattern in a case of pulmonary venoocclusive disease","volume":"18","author":"Sol\u00e1","year":"1993","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib56","first-page":"1321","article-title":"High-resolution CT of the chest in four patients with pulmonary capillary hemangiomatosis or pulmonary venoocclusive disease","volume":"171","author":"Dufour","year":"1998","journal-title":"Am J Radiol"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib57","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.2214\/ajr.166.6.8633450","article-title":"Accuracy of high-resolution ct in identifying chronic pulmonary thromboembolic disease","volume":"166","author":"Bergin","year":"1996","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib58","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0003-4975(97)01413-6","article-title":"Lung transplantation for primary pulmonary hypertension and giant pulmonary artery aneurysm","volume":"65","author":"Wekerle","year":"1998","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib59","doi-asserted-by":"crossref","first-page":"128","DOI":"10.2214\/AJR.04.0833","article-title":"Hemodynamic effects of monomeric nonionic contrast media in pulmonary angiography in chronic thromboembolic pulmonary hypertension","volume":"187","author":"Pitton","year":"2006","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib60","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1148\/radiology.182.2.1732955","article-title":"Chronic major-vessel thromboembolic pulmonary artery obstruction: Appearance at angiography","volume":"182","author":"Auger","year":"1992","journal-title":"Radiology"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib61","first-page":"919","article-title":"The 6-minute walk: A new measure of exercise capacity in patients with chronic heart failure","volume":"132","author":"Guyatt","year":"1985","journal-title":"CMAJ"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib62","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/01.CIR.0000022687.18568.2A","article-title":"Assessment of survival in patients with primary pulmonary hypertension: Importance of cardiopulmonary exercise testing","volume":"106","author":"Wensel","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib63","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1161\/hc2901.093198","article-title":"Exercise pathophysiology in patients with primary pulmonary hypertension","volume":"104","author":"Sun","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib64","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jacc.2009.01.004","volume":"53","author":"McLaughlin","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib65","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1378\/chest.08-2784","article-title":"Misclassification of pulmonary hypertension due to reliance on pulmonary capillary wedge pressure rather than left ventricular end-diastolic pressure","volume":"136","author":"Halpern","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib66","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1164\/ajrccm.160.2.9811062","article-title":"Determination of cardiac output by the Fick method, thermodilution, and acetylene rebreathing in pulmonary hypertension","volume":"160","author":"Hoeper","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib67","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1378\/chest.06-2690","article-title":"Right ventricular pressure waveform and wave reflection analysis in patients with pulmonary arterial hypertension","volume":"132","author":"Karamanoglu","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib68","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1161\/CIRCULATIONAHA.105.601930","article-title":"Relationship of bmpr2 mutations to vasoreactivity in pulmonary arterial hypertension","volume":"113","author":"Elliott","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib69","doi-asserted-by":"crossref","first-page":"195S","DOI":"10.1378\/chest.114.3_Supplement.195S","article-title":"Primary pulmonary hypertension associated with the use of fenfluramine derivatives","volume":"114","author":"Simonneau","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib70","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1002\/1529-0131(199912)42:12<2638::AID-ANR20>3.0.CO;2-X","article-title":"Systemic sclerosis-associated pulmonary hypertension: Short- and long-term effects of epoprostenol (prostacyclin)","volume":"42","author":"Klings","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib71","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1161\/CIRCULATIONAHA.104.488486","article-title":"Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension","volume":"111","author":"Sitbon","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib72","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.rmed.2003.09.019","article-title":"Clinical value of vasodilator test with inhaled nitric oxide for predicting long-term response to oral vasodilators in pulmonary hypertension","volume":"98","author":"Morales-Blanhir","year":"2004","journal-title":"Respir Med"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib73","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/0140-6736(91)92033-X","article-title":"Inhaled nitric oxide as a cause of selective pulmonary vasodilation in pulmonary hypertension","volume":"338","author":"Pepke-Zaba","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib74","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1161\/01.CIR.66.2.334","article-title":"Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension","volume":"66","author":"Rubin","year":"1982","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib75","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/0735-1097(92)90295-X","article-title":"Comparison of the effects of adenosine and nifedipine in pulmonary hypertension","volume":"19","author":"Schrader","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib76","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0002-9149(94)90496-0","article-title":"Inhaled nitric oxide leading to pulmonary edema in stable severe heart failure","volume":"74","author":"Bocchi","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib77","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.jacc.2009.04.017","article-title":"Updated evidence-based treatment algorithm in pulmonary arterial hypertension","volume":"54","author":"Barst","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib78","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","volume":"30","author":"Galie","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib79","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1378\/chest.06-2674","article-title":"Medical therapy for pulmonary arterial hypertension: Updated ACCP evidence-based clinical practice guidelines","volume":"131","author":"Badesch","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib80","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jacc.2010.11.020","article-title":"Compelling evidence of long-term outcomes in pulmonary arterial hypertension?","volume":"57","author":"Gomberg-Maitland","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib81","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1161\/CIRCULATIONAHA.106.618397","article-title":"Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension","volume":"114","author":"Mereles","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib82","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/S0735-1097(98)00162-4","article-title":"Outcome of pulmonary vascular disease in pregnancy: A systematic overview from 1978 through 1996","volume":"31","author":"Weiss","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib83","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM199207093270203","article-title":"The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension","volume":"327","author":"Rich","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib84","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1378\/chest.112.3.714","article-title":"The effect of anticoagulant therapy in primary and anorectic drug-induced pulmonary hypertension","volume":"112","author":"Frank","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib85","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.CIR.70.4.580","article-title":"Primary pulmonary hypertension: Natural history and the importance of thrombosis","volume":"70","author":"Fuster","year":"1984","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib86","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension","volume":"334","author":"Barst","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib87","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/01.CIR.0000029100.82385.58","article-title":"Survival in primary pulmonary hypertension: the impact of epoprostenol therapy","volume":"106","author":"McLaughlin","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib88","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0735-1097(02)02012-0","article-title":"Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: Prognostic factors and survival","volume":"40","author":"Sitbon","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib89","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-132-6-200003210-00002","article-title":"Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease","volume":"132","author":"Badesch","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib90","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1164\/rccm.200204-333OC","article-title":"Outcome in 91 consecutive patients with pulmonary arterial hypertension receiving epoprostenol","volume":"167","author":"Kuhn","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib91","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1161\/01.CIR.99.14.1858","article-title":"Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects","volume":"99","author":"Rosenzweig","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib92","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1164\/ajrccm.162.5.2004042","article-title":"Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension","volume":"162","author":"Aguilar","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib93","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/00007890-199702270-00020","article-title":"Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension","volume":"63","author":"Kuo","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib94","doi-asserted-by":"crossref","first-page":"740","DOI":"10.7326\/0003-4819-130-9-199905040-00014","article-title":"Compassionate use of continuous prostacyclin in the management of secondary pulmonary hypertension: A case series","volume":"130","author":"McLaughlin","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib95","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1164\/rccm.200204-330OC","article-title":"Prognostic factors for survival in human immunodeficiency virus-associated pulmonary arterial hypertension","volume":"167","author":"Nunes","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib96","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1164\/ajrccm.165.6.2106079","article-title":"Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension","volume":"165","author":"Simonneau","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib97","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1378\/chest.129.3.683","article-title":"Safety and efficacy of IV treprostinil for pulmonary arterial hypertension: A prospective, multicenter, open-label, 12-week trial","volume":"129","author":"Tapson","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib98","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1164\/rccm.200505-766OC","article-title":"Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension","volume":"172","author":"Gomberg-Maitland","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib99","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.healun.2009.09.005","article-title":"Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial hypertension: A placebo-controlled trial","volume":"29","author":"Hiremath","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib100","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jacc.2010.01.027","article-title":"Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: A randomized controlled clinical trial","volume":"55","author":"McLaughlin","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib101","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa020204","article-title":"Inhaled iloprost for severe pulmonary hypertension","volume":"347","author":"Olschewski","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib102","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(01)06250-X","article-title":"Effects of the dual endothelin-receptor anatgonist bosentan in patients with pulmonary hypertension: A randomised placebo-controlled study","volume":"358","author":"Channick","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib103","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan therapy for pulmonary arterial hypertension","volume":"346","author":"Rubin","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib104","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(08)60919-8","article-title":"Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (early study): A double-blind, randomised controlled trial","volume":"371","author":"Galie","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib105","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/CIRCULATIONAHA.106.630715","article-title":"Bosetan therapy in patients with eisenmenger Syndrom: A multicenter, double-blind, randomized, placebo-controlled study","volume":"114","author":"Galie","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib106","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jacc.2005.04.050","article-title":"Ambrisentan therapy for pulmonary arterial hypertension","volume":"46","author":"Galie","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib107","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil citrate therapy for pulmonary arterial hypertension","volume":"353","author":"Galie","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib108","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1161\/CIRCULATIONAHA.108.839274","article-title":"Tadalafil therapy for pulmonary arterial hypertension","volume":"119","author":"Galie","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib109","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1136\/thorax.58.9.797","article-title":"Atrial septostomy in the treatment of severe pulmonary arterial hypertension","volume":"58","author":"Reichenberger","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib110","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0002-9149(99)00416-6","article-title":"Atrial septostomy as a bridge to lung transplantation in patients with severe pulmonary hypertension","volume":"84","author":"Rothman","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib111","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0735-1097(98)00238-1","article-title":"Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension","volume":"32","author":"Sandoval","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib112","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","article-title":"Survival in patients with primary pulmonary hypertension","volume":"115","author":"D'Alonzo","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib113","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/CIRCULATIONAHA.109.911818","article-title":"Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era","volume":"122","author":"Humbert","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib114","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.109.898122","article-title":"Predicting survival in pulmonary arterial hypertension: Insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management (REVEAL)","volume":"122","author":"Benza","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib115","doi-asserted-by":"crossref","first-page":"78S","DOI":"10.1378\/chest.126.1_suppl.78S","article-title":"Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines","volume":"126","author":"McLaughlin","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib116","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1136\/hrt.2005.069484","article-title":"Systemic sclerosis associated pulmonary hypertension: Improved survival in the current era","volume":"92","author":"Williams","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib117","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0002-9149(99)00415-4","article-title":"Determinants of survival and length of survival in adults with Eisenmenger syndrome","volume":"84","author":"Cantor","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib118","first-page":"165","article-title":"Primary pulmonary hypertension: Natural history and prognostic factors","volume":"46","author":"Rajasekhar","year":"1994","journal-title":"Indian Heart J"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib119","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1378\/chest.119.6.1801","article-title":"Primary pulmonary hypertension in Israel: A national survey","volume":"119","author":"Appelbaum","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib120","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1161\/01.CIR.89.4.1733","article-title":"Survival in primary pulmonary hypertension: Validation of a prognostic equation","volume":"89","author":"Sandoval","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib121","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0735-1097(97)00452-X","article-title":"Plasma brain natriuretic peptide levels increase in proportion to the extent of reight ventricular dysfunction in pulmonary hypertension","volume":"31","author":"Nagaya","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib122","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1527-5299.2004.03881.x","article-title":"Usefulness of b-type natriuertic peptide as a predictor of treatment outcome in pulmonary arterial hypertension","volume":"10","author":"Park","year":"2004","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib123","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1378\/chest.129.5.1313","article-title":"Serum n-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension","volume":"129","author":"Fijalkowska","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib124","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.jacc.2009.04.011","article-title":"Diagnosis and assessment of pulmonary arterial hypertension","volume":"54","author":"Badesch","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib125","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1183\/09031936.05.00075305","article-title":"Goal-oriented treatment and combination therapy for pulmonary arterial hypertension","volume":"26","author":"Hoeper","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib126","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1161\/01.CIR.102.14.1718","article-title":"Secondary pulmonary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management","volume":"102","author":"Moraes","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib127","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1513\/pats.200411-053SF","article-title":"Pulmonary hypertension and chronic obstructive lung disease a case for treatment","volume":"2","author":"Higenbottam","year":"2005","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib128","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1513\/pats.200407-037MS","article-title":"Pulmonary hypertension and right heart failure in chronic obstructive pulmonary disease","volume":"2","author":"Naeije","year":"2004","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib129","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1164\/rccm.200401-006OC","article-title":"Severe pulmonary hypertension and chronic obstructive pulmonary disease","volume":"172","author":"Chaouat","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib130","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1161\/01.CIR.0000091409.53101.E8","article-title":"Polymorphism of the serotonin transporter gene and pulmonary hypertension in chronic obstructive pulmonary disease","volume":"108","author":"Eddahibi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib131","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1164\/rccm.2107027","article-title":"Hemodynamic characterization of patients with severe emphysema","volume":"166","author":"Scharf","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib132","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1056\/NEJMoa032274","article-title":"Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism","volume":"350","author":"Pengo","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib133","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/00001721-200109000-00002","article-title":"Thrombophilic factors in chronic thromboembolic pulmonary hypertension","volume":"12","author":"Colorio","year":"2001","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib134","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1055\/s-0038-1650603","article-title":"No increased prevalence of the factor V Leiden mutation in chronic major vessel thromboembolic pulmonary hypertension (CTEPH) [Letter]","volume":"76","author":"Lang","year":"1996","journal-title":"Thromb H\u00e6most"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib135","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1034\/j.1399-3003.2000.15b28.x","article-title":"Thrombotic risk factors in pulmonary hypertension","volume":"15","author":"Wolf","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib136","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1160\/TH03-02-0067","article-title":"High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension","volume":"90","author":"Bonderman","year":"2003","journal-title":"Thromb H\u00e6most"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib137","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1183\/09031936.98.12061446","article-title":"Plasma coagulation profiles in patients with severe primary pulmonary hypertension","volume":"12","author":"Hoeper","year":"1998","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib138","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1160\/TH04-10-0657","article-title":"Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension","volume":"93","author":"Bonderman","year":"2005","journal-title":"Thromb H\u00e6most"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib139","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1136\/thx.2004.038083","article-title":"Splenectomy and chronic thromboembolic pulmonary hypertension","volume":"60","author":"Jais","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib140","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1161\/CIRCULATIONAHA.106.661041","article-title":"Predictors of outcome in chronic thromboembolic pulmonary hypertension","volume":"115","author":"Bonderman","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib141","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1183\/09031936.00087608","article-title":"Risk factors for chronic thromboembolic pulmonary hypertension","volume":"33","author":"Bonderman","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib142","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1043-0679(99)70007-9","article-title":"Historical perspective: Surgery for chronic thromboembolic disease","volume":"11","author":"Daily","year":"1999","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib143","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S0003-4975(03)00828-2","article-title":"Pulmonary endarterectomy: Experience and lessons learned in 1,500 cases","volume":"76","author":"Jamieson","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib144","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1164\/rccm.200712-1841OC","article-title":"Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension","volume":"177","author":"Condliffe","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib145","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1513\/pats.200605-115LR","article-title":"Medical therapies for chronic thromboembolic pulmonary hypertension: an evolving treatment paradigm","volume":"3","author":"Bresser","year":"2006","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib146","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1183\/09031936.04.00020004","article-title":"Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension","volume":"23","author":"Bresser","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib147","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1378\/chest.123.2.338","article-title":"Prostacyclin therapy before pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension","volume":"123","author":"Nagaya","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib148","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1378\/chest.128.4.2363","article-title":"Bosentan therapy for inoperable chronic thromboembolic pulmonary hypertension","volume":"128","author":"Hoeper","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib149","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1136\/thx.2005.046961","article-title":"Bosentan in inoperable chronic thromboembolic pulmonary hypertension","volume":"60","author":"Hughes","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib150","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1378\/chest.128.4.2599","article-title":"Bosentan therapy for inoperable chronic thromboembolic pulmonary hypertension","volume":"128","author":"Bonderman","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib151","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1183\/09031936.00039007","article-title":"Long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertension","volume":"30","author":"Reichenberger","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib152","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.jacc.2008.08.059","article-title":"Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: Benefit (bosentan effects in inoperable forms of chronic thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial","volume":"52","author":"Jais","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib153","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1378\/chest.123.2.319","article-title":"Epoprostenol therapy as a bridge to pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension","volume":"123","author":"Kerr","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.cpcardiol.2011.08.002_bib154","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1183\/09059180.00007409","article-title":"Surgical and post-operative treatment of chronic thromboembolic pulmonary hypertension","volume":"19","author":"Mayer","year":"2010","journal-title":"Eur Respir Rev"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280611001873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280611001873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T18:21:03Z","timestamp":1593195663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280611001873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":154,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0146280611001873"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2011.08.002","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}